Pharmaguy™ Interviews Dyan Byson: Patient-Centric Marketing: Measure Differently for Healthier Returns

In this 2-minute snippet Dyan Byson, Managing Director, Inspired Health Strategies, LLC, urges pharma marketers to 'measure differently' by going beyond IMS NRx (new prescription) data and following what happens AFTER the prescription is filled to better understand the patient and implement 'patient-centric' marketing.

Bad, Devalued, Distrusted & Defensive Pharma

You know the Tale of Two Cities. This article, however, tells the Tale of Two Books: Bad Pharma, a 430-page book by Ben Goldacre, a British physician, whose previous book, Bad Science, was a best seller in the non-fiction realm and the much smaller 123-page book Devalued and Distrusted by John L. LaMattina, former president of research and develop at Pfizer.

Pharmaguy’s Pharma Predictions

To usher in the New Year, it's traditional for pundits like Pharmaguy (aka John Mack, Publisher of Pharma Marketing News) to go out on a limb and make a few pharma industry predictions for the year. To compile his list, Pharmaguy used data from surveys, interviewed a pharmaceutical executive, and looked at the past year as an indication of what may be important in 2013 and beyond.

Bad, Devalued, Distrusted & Defensive Pharma

This article, however, tells the Tale of Two Books: Bad Pharma, a 430-page book by Ben Goldacre, a British physician, whose previous book, Bad Science, was a best seller in the 'non-fiction' realm and the much smaller 123-page book Devalued and Distrusted by John L. LaMattina, former president of research and develop at Pfizer.

Pharmaguy’s Pharma Predictions

To usher in the New Year, it's traditional for pundits like Pharmaguy (aka John Mack, Publisher of Pharma Marketing News) to go out on a limb and make a few pharma industry predictions for the year.

Some Interesting Pharma Predictions for 2013

It's appropriate that I present a few pharma industry predictions for 2013 in the last post of the year to Pharma Marketing Blog. To compile the...

My Prediction for 2013: No Social Media Guidance from FDA

A month ago, I wrote an "open letter" to Megan Clark Velez, MPH, Office of the FDA Commissioner, asking her for more transparency regarding...

Nominate Me (@Pharmaguy) for #Pharma100

My Twitter pal Henry Gazay, CEO, Medimix International, is at it again. He's compiling the #pharma100 crowdsourced list of the top100 Social media pharma...

Pharma Marketing News Vol. 11, No. 11: 27 December 2012

Welcome to Volume 11, Issue #11 (27 December 2012) of Pharma Marketing News.

Happy Holidays from Professor Syrum: Bah. Humbug!

Thanks to everyone wishing me "Happy Holidays," including "Professor Syrum" from Boehringer Ingelheim's Syrum Facebook game. The good Prof sent me this e-mail holiday...